Dr. Meaglia now offers revolutionary Rezum® therapy to select BPH patients
LAGUNA HILLS, Calif. (October 18, 2017) – Dr. James Meaglia is now offering patients the Rezūm® system, a minimally invasive treatment option for men with benign prostatic hyperplasia (BPH). Designed to be performed in a clinical setting, Rezūm is an FDA approved treatment that uses the stored thermal energy in water vapor (steam) to treat the extra prostate tissue that is causing symptoms such as frequency, urgency, irregular flow, weak stream, straining, and getting up at night to urinate.
BPH is a localized enlargement of the prostate gland in aging adult men. Nearly 12 million U.S. men suffer from BPH related symptoms that may require therapy, yet more than half choose not to do anything to address their BPH symptoms. Their reasons include not wanting to start new prescriptions, hesitations around the potential side effects of drugs, and concerns about the potential side effects or complications of current minimally invasive BPH treatments or surgical procedures.
“I am pleased to now offer select patients the Rezūm® procedure as a treatment for benign prostatic hyperplasia (BPH). Rezūm is administered on an outpatient basis and can be performed under oral sedation or local anesthesia. Research studies have shown that the Rezūm treatment allows men to retain sexual function unlike many other existing BPH treatments,” Dr. Meaglia said.
Highlights of the therapy include:
- Performed in-office and patients can return home immediately
- Does not require general anesthesia
- Relieves symptoms safely and effectively
- Is an alternative to BPH daily medications
- Provides noticeable symptom improvement within 2 weeks
- Preserves erectile and urinary functions
- Allows patients to return to regular activities within a few days; and
- Is considered medically necessary by Medicare and is covered by most private insurance.
Patients interested in a consultation with Dr. Meaglia to determine if they are a candidate for the Rezūm® system should call appointment scheduling at (949) 855-1101.
McVary KT, Gange SN, Gittelman MC, et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. The Journal of Urology. 016;195(5):1529-1538. doi:10.1016/j.juro.2015.10.181.